On Monday, March 7, 2016, Congressman Lloyd Doggett, D-Texas, issued a statement in support of the recent Knowledge Ecology International (KEI) and Union for Affordable Cancer Treatment (UACT) request that the National Institutes of Health (NIH) authorize the generic production of an expensive prostate cancer drug in order to curb an excessive and discriminatory price in the United States.
The World Intellectual Property Organization’s (WIPO) Twenty-Second session of the Standing Committee on the Law of Patents (SCP) will be convened from 27 July 2015 to 31 July 2015 in Geneva, Switzerland. For consideration of the Committee, the Group of Latin American and Caribbean Countries (GRULAC) have submitted a proposal entitled, Revision of 1979 WIPO Model Law for Developing Countries on Inventions (SCP/22/5). Continue Reading
In discussions at the June 2015 WTO TRIPS Council on the role of intellectual property in financing innovation, India underscored its commitment to the principle of de-linkage by stating,
Innovation should not be viewed within the narrow prism of intellectual property monopolies but framed within a holistic, knowledge ecosystem that includes open innovation, open knowledge approaches and de-linkage of R&D costs from product prices
On Friday, 8 May 2015, the World Health Organization (WHO) unveiled its 19th WHO Model of Essential Medicines (April 2015).
With respect to cancer drugs (Section 8.2, Cytoxic and Adjuvant Medicines), the Executive Summary noted that the Committee added 16 new medicines.
TRIPS Council (October 2014): India calls for de-linkage and innovation inducement prizes at WTO discussions on IP & innovation
In advance of the World Trade Organization’s October 2014 session of the TRIPS Council, the European Union, Switzerland and the United States made a written request to the TRIPS Council to discuss “Intellectual Property and Innovation: Promoting Awareness; Case Studies” under agenda item 12. This marked the 7th time that the United States tabled an item to the TRIPS Council relating to intellectual property or innovation.
In the context of these October 2014 discussions of Intellectual Property and Innovation, the Government of India delivered the following intervention asserting that,
NIH rejects March-In petition, also rejects proposed rules on pricing of and access to government funded inventions
In a decision dated November 1, 2013, and signed by NIH Director Francis Collins, the NIH has rejected the 2012 petition to the NIH to uses its powers under the Bayh-Dole Act to protect U.S. consumers from high prices and restrictive licensing of NIH funded inventions.
White House refuses FOIA request for documents on country positions on transparency of ACTA negotiations
On June 2, 2010, KEI submitted a FOIA request to the White House Office of the United States Trade Representative (USTR). The request covered:
The language in S. 3187, calling for National Academies evaluation of Medical Innovation inducement prizes
S.3187 Food and Drug Administration Safety and Innovation Act (Engrossed in Senate [Passed Senate] – ES)SEC. 906. INDEPENDENT STUDY ON MEDICAL INNOVATION INDUCEMENT MODEL.
Cables from Chile illustrate ongoing pressure by US trade officials on behalf of drug companies
Wikileaks has published several cables invovling Chile, a country that signed an FTA with the United States/ When the Chile/US FTA came into effect in 2004, it was the template for a series of subsequent Bush Administration FTA agreements that ramped up IPR protections for pharmacetuicals and copyrights, and it seemed aggressive at the time. Continue Reading
“Ipr In Italy – American Voices Among Italian Elite,”cooperation and how to make them change their mind (cables)
Cable reference id: #09ROME1396
Subject Ipr In Italy – American Voices Among Italian Elite
Origin Embassy Rome (Italy)
Cable time Mon, 21 Dec 2009 15:30 UTC
Classification UNCLASSIFIED
Source http://wikileaks.org/cable/2009/12/09ROME1396.html
History First published on Fri, 26 Aug 2011 02:34 UTC
Modified on Thu, 1 Sep 2011 23:24 UTC
Media?Add media item
Comments 0 Comments
Continue Reading